Rasburicase Treatment in Chronic Gouty Arthritis
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2023-05-09
- Target Recruit Count
- 60
- Registration Number
- NCT05312268
- Locations
- 🇨🇳
Shenshan Medical Center, Shanwei, Guangdong, China
🇨🇳Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Shunde Hospital of Southern Medical University, Foshan, Guangdong, China
A Prospective Observational Study of Sepsis
- Conditions
- Sepsis
- Interventions
- Other: no intervention
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2022-05-31
- Target Recruit Count
- 174
- Registration Number
- NCT05309889
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-07-01
- Target Recruit Count
- 64
- Registration Number
- NCT05303727
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Target Recruit Count
- 204
- Registration Number
- NCT05303259
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
A Prospective, Multicenter Cohort Study of Urinary Exosome lncRNAs for Preoperative Diagnosis of Lymphatic Metastasis in Patients With Bladder Cancer
- Conditions
- Explore Whether lncRNA-ElNAT1 in Urine Exosomes Can be Used as a New Target for Preoperative Diagnosis of Lymph Node Metastasis
- Interventions
- Other: no intervention
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 74
- Registration Number
- NCT05270174
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hosptial, Guangzhou, China
A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast
- Conditions
- The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-03-04
- Target Recruit Count
- 1500
- Registration Number
- NCT05267327
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
- Conditions
- Ovarian Cancer
- Interventions
- Procedure: HIPEC
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2023-02-17
- Target Recruit Count
- 310
- Registration Number
- NCT05265117
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation
- Conditions
- Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Carcinoma
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-03-02
- Target Recruit Count
- 30
- Registration Number
- NCT05262608
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
- Conditions
- Ovarian Cancer
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2023-05-19
- Target Recruit Count
- 200
- Registration Number
- NCT05251883
- Locations
- 🇨🇳
The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit, Guangzhou, Guangdong, China
Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial)
- Conditions
- Hyperthermic Intraperitoneal ChemotherapyNeoadjuvant Chemotherapy
- Interventions
- Procedure: intravenous chemotherapyProcedure: HIPEC
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2022-02-18
- Target Recruit Count
- 80
- Registration Number
- NCT05246020
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Other (Non U.s.), China